Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketamine with propofol for laryngeal mask airway insertion during diagnostic hysteroscopy
PACTR202605546376442Phase 4Not yet recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, ketamine and propofol in Not applicable (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Laryngeal Mask Airway insertion conditions. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineketaminepropofol
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202605546376442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605546376442.